Financial statements Podkarpackie Centrum Leczenia Chorób Cywilizacyjnych Medicarpathia W Upadłości
Balance sheet data of PODKARPACKIE CENTRUM LECZENIA CHORÓB CYWILIZACYJNYCH MEDICARPATHIA W UPADŁOŚCI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 696 846,68 | 1 284 707,84 | 831 466,01 | 468 911,80 | 214 171,11 | 160 336,25 |
| A. Fixed assets | 1 450 241,86 | 1 154 496,03 | 765 103,05 | 380 118,96 | 161 651,07 | 111 080,31 |
| B. Current assets | 246 604,82 | 130 211,81 | 66 362,96 | 31 273,02 | 52 520,04 | 49 255,94 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | 57 519,82 | - | - |
| Total liabilities | 1 696 846,68 | 1 284 707,84 | 831 466,01 | 468 911,80 | 214 171,11 | 160 336,25 |
| A. Equity | -299 731,19 | -1 061 870,06 | -1 847 157,71 | -2 109 061,95 | -2 422 866,36 | -2 708 628,78 |
| B. Liabilities and provisions for liabilities | 1 996 577,87 | 2 346 577,90 | 2 678 623,72 | 2 577 973,75 | 2 637 037,47 | 2 868 965,03 |
| I. Long-term liabilities | 1 641 879,11 | 1 175 996,39 | 876 089,84 | 430 401,63 | 0,00 | 0,00 |
| II. Short-term liabilities | 354 698,76 | 1 170 581,51 | 1 802 533,88 | 2 107 072,12 | 2 623 537,47 | 2 868 965,03 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.